Search

Search Constraints

You searched for: Author/Creator Boyer, M.

Search Results

1. 147P Characterizing CRS in phase I study of DLL3-targeted T cell engager tarlatamab in small cell lung cancer. (December 2022)

3. Afatinib vs gefitinib in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC: overall survival (OS) data from LUX-Lung 7 (LL7). (February 2017)

5. DIII-D research advancing the physics basis for optimizing the tokamak approach to fusion energy. (1st April 2022)

7. First-line afatinib for advanced EGFR mutation-positive (EGFRm+) NSCLC: analysis of long-term responders in the Phase III LUX-Lung 3, 6 and 7 trials. (February 2017)

8. Fusion nuclear science facilities and pilot plants based on the spherical tokamak. (16th August 2016)

10. IMPACT OF MAJOR GENOMIC ALTERATIONS ON OUTCOME OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS RECEIVING VENETOCLAX PLUS RITUXIMAB IN THE PHASE 3 MURANO STUDY. (12th June 2019)